Mesenchymal stem cells from human amniotic membrane differentiate into cardiomyocytes and endothelial-like cells without improving cardiac function after surgical administration in rat model of chronic heart failure

Introduction: Human amnion-derived mesenchymal stem cells (hAMSCs) have been used in the treatment of acute myocardial infarction. In the current study, we investigated the efficacy of hAMSCs for the treatment of chronic model of myocardial ischemia and heart failure (HF) in rats. Methods: Male Wist...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorjipour, Fazel, Hosseini-Gohari, Ladan, Alizadeh Ghavidel, Alireza, Hajimiresmaiel, Seyed Javad, Naderi, Nasim, Darbandi Azar, Amir, Pazoki-Toroudi, Hamidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477105/
https://www.ncbi.nlm.nih.gov/pubmed/31024670
http://dx.doi.org/10.15171/jcvtr.2019.06

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477105/
https://www.ncbi.nlm.nih.gov/pubmed/31024670
http://dx.doi.org/10.15171/jcvtr.2019.06

Ejemplares similares